| Year |
Citation |
Score |
| 2017 |
Woods AN, Wilson AL, Srivinisan N, Zeng J, Dutta AB, Peske JD, Tewalt EF, Gregg RK, Ferguson AR, Engelhard VH. Differential expression of homing receptor ligands on tumor associated vasculature that control CD8 effector T cell entry. Cancer Immunology Research. PMID 29097419 DOI: 10.1158/2326-6066.Cir-17-0190 |
0.393 |
|
| 2015 |
Rouhani SJ, Eccles JD, Riccardi P, Peske JD, Tewalt EF, Cohen JN, Liblau R, Mäkinen T, Engelhard VH. Roles of lymphatic endothelial cells expressing peripheral tissue antigens in CD4 T-cell tolerance induction. Nature Communications. 6: 6771. PMID 25857745 DOI: 10.1038/Ncomms7771 |
0.592 |
|
| 2014 |
Rouhani SJ, Eccles JD, Tewalt EF, Engelhard VH. Regulation of T-cell Tolerance by Lymphatic Endothelial Cells. Journal of Clinical & Cellular Immunology. 5. PMID 25580369 DOI: 10.4172/2155-9899.1000242 |
0.475 |
|
| 2014 |
Cohen JN, Tewalt EF, Rouhani SJ, Buonomo EL, Bruce AN, Xu X, Bekiranov S, Fu YX, Engelhard VH. Tolerogenic properties of lymphatic endothelial cells are controlled by the lymph node microenvironment. Plos One. 9: e87740. PMID 24503860 DOI: 10.1371/Journal.Pone.0087740 |
0.418 |
|
| 2013 |
Rival C, Wheeler K, Jeffrey S, Qiao H, Luu B, Tewalt EF, Engelhard VH, Tardif S, Hardy D, del Rio R, Teuscher C, Tung K. Regulatory T cells and vasectomy. Journal of Reproductive Immunology. 100: 66-75. PMID 24080233 DOI: 10.1016/J.Jri.2013.08.004 |
0.482 |
|
| 2012 |
Tewalt EF, Cohen JN, Rouhani SJ, Engelhard VH. Lymphatic endothelial cells - key players in regulation of tolerance and immunity. Frontiers in Immunology. 3: 305. PMID 23060883 DOI: 10.3389/Fimmu.2012.00305 |
0.571 |
|
| 2012 |
Tewalt EF, Cohen JN, Rouhani SJ, Guidi CJ, Qiao H, Fahl SP, Conaway MR, Bender TP, Tung KS, Vella AT, Adler AJ, Chen L, Engelhard VH. Lymphatic endothelial cells induce tolerance via PD-L1 and lack of costimulation leading to high-level PD-1 expression on CD8 T cells. Blood. 120: 4772-82. PMID 22993390 DOI: 10.1182/Blood-2012-04-427013 |
0.543 |
|
| 2010 |
Cohen JN, Guidi CJ, Tewalt EF, Qiao H, Rouhani SJ, Ruddell A, Farr AG, Tung KS, Engelhard VH. Lymph node-resident lymphatic endothelial cells mediate peripheral tolerance via Aire-independent direct antigen presentation. The Journal of Experimental Medicine. 207: 681-8. PMID 20308365 DOI: 10.1084/Jem.20092465 |
0.557 |
|
| 2009 |
Tewalt EF, Grant JM, Granger EL, Palmer DC, Heuss ND, Gregerson DS, Restifo NP, Norbury CC. Viral sequestration of antigen subverts cross presentation to CD8(+) T cells. Plos Pathogens. 5: e1000457. PMID 19478869 DOI: 10.1371/Journal.Ppat.1000457 |
0.595 |
|
| 2008 |
Tewalt EF, Maynard JC, Walters JJ, Schell AM, Berwin BL, Nicchitta CV, Norbury CC. Redundancy renders the glycoprotein 96 receptor scavenger receptor A dispensable for cross priming in vivo. Immunology. 125: 480-91. PMID 18489571 DOI: 10.1111/J.1365-2567.2008.02861.X |
0.779 |
|
| 2007 |
Reiley WW, Jin W, Lee AJ, Wright A, Wu X, Tewalt EF, Leonard TO, Norbury CC, Fitzpatrick L, Zhang M, Sun SC. Deubiquitinating enzyme CYLD negatively regulates the ubiquitin-dependent kinase Tak1 and prevents abnormal T cell responses. The Journal of Experimental Medicine. 204: 1475-85. PMID 17548520 DOI: 10.1084/Jem.20062694 |
0.652 |
|
| 2006 |
Donohue KB, Grant JM, Tewalt EF, Palmer DC, Theoret MR, Restifo NP, Norbury CC. Cross-priming utilizes antigen not available to the direct presentation pathway. Immunology. 119: 63-73. PMID 16764686 DOI: 10.1111/J.1365-2567.2006.02406.X |
0.62 |
|
| 2006 |
Norbury CC, Tewalt EF. Upstream toward the "DRiP"-ing source of the MHC class I pathway. Immunity. 24: 503-6. PMID 16713966 DOI: 10.1016/J.Immuni.2006.05.007 |
0.627 |
|
| Show low-probability matches. |